"Mycosis Fungoides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.
| Descriptor ID |
D009182
|
| MeSH Number(s) |
C04.557.386.480.750.800.550 C15.604.515.569.480.750.800.550 C20.683.515.761.480.750.800.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycosis Fungoides".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, T-Cell, Cutaneous [C04.557.386.480.750.800]
- Mycosis Fungoides [C04.557.386.480.750.800.550]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Lymphoma, T-Cell, Cutaneous [C15.604.515.569.480.750.800]
- Mycosis Fungoides [C15.604.515.569.480.750.800.550]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]
- Mycosis Fungoides [C20.683.515.761.480.750.800.550]
Below are MeSH descriptors whose meaning is more specific than "Mycosis Fungoides".
This graph shows the total number of publications written about "Mycosis Fungoides" by people in this website by year, and whether "Mycosis Fungoides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycosis Fungoides" by people in Profiles.
-
Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA). Best Pract Res Clin Haematol. 2023 03; 36(1):101448.
-
Increasing incidence of pediatric mycosis fungoides from 2000 to 2017: A national population-based study of the Surveillance, Epidemiology, and End Results database and Texas Cancer Registry. J Am Acad Dermatol. 2023 01; 88(1):185-187.
-
A comparative analysis of histone deacetylase inhibitors for the treatment of mycosis fungoides and S?zary syndrome. Br J Dermatol. 2020 02; 182(2):497-498.
-
Waistband Mycosis Fungoides: A New Clinical Variant of Early-Stage Disease. Skinmed. 2019; 17(5):329-332.
-
The Challenge of Diagnosing Mycosis Fungoides. Am J Dermatopathol. 2016 07; 38(7):567-8.
-
Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature. J Am Acad Dermatol. 2015 Dec; 73(6):976-86.
-
Genomic analysis of mycosis fungoides and S?zary syndrome identifies recurrent alterations in TNFR2. Nat Genet. 2015 Sep; 47(9):1056-60.
-
Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. Hum Pathol. 2015 Apr; 46(4):558-69.
-
Vitamin D deficiency in mycosis fungoides and S?zary syndrome patients is similar to other cancer patients. Clin Lymphoma Myeloma Leuk. 2014 Dec; 14(6):518-24.
-
Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and S?zary syndrome. Clin Cancer Res. 2015 Jan 15; 21(2):274-85.